Valued at a market cap of $54.8 billion, Cencora, Inc. (COR) is a global healthcare solutions provider. Headquartered in ...

Cencora Inc. closed 3.50% below its 52-week high of $296.65, which the company reached on April 4th.

Shares of Cencora Inc. COR shed 1.95% to $281.16 Monday, on what proved to be an all-around grim trading session for the ...

We came across a bullish thesis on Cencora, Inc. (COR) on Substack by Hidden Market Gems. In this article, we will summarize the bulls’ thesis on COR. Cencora, Inc. (COR)'s share was trading at ...

CONSHOHOCKEN, Pa., March 28, 2025--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the ...

Cencora COR -0.56% Get Free Report has outperformed the market over the past 5 years by 12.25% on an annualized basis ...

In its first-quarter 2025 investor letter, Carillon Eagle Mid Cap Growth Fund highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products distributor.

Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. Growth stocks are ...